The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Cellectar Biosciences, Inc. - Oncology-focused Biopharmaceutical Company Highlights Corporate Updates and Clinical Development

SNNLive spoke with Jim Caruso, President & CEO of Cellectar Biosciences, Inc. (NASDAQ: CLRB) at the Marcum MicroCap Conference 2016 in New York City, NY.

Share With

Thursday, July 21, 2016

   

© 2017 Stock News Now